Yesterday, the U.S. Department of Health and Human Services finalized a rule expanding short-term, limited-duration insurance plans -- threatening access to adequate, affordable coverage for people with cystic fibrosis who rely on the individual marketplace.
Site Search
Showing 1 - 10 of 17 results
News
|
March 2, 2009
|
1 min read
News
|
Aug. 1, 2008
|
1 min read
News
|
Aug. 2, 2018
|
2 min read
News
|
Aug. 11, 2014
|
2 min read
News
|
Feb. 15, 2007
|
2 min read
News
|
Aug. 11, 2014
|
1 min read
News
|
Dec. 28, 2007
|
1 min read
PTC Therapeutics has discontinued development of ataluren as a potential treatment for people with cystic fibrosis caused by a nonsense mutation. The Cystic Fibrosis Foundation is supporting efforts to pursue treatments for people with CF who have a nonsense, splicing or other rare mutations.
News
|
March 3, 2017
|
3 min read
On March 20, the Cystic Fibrosis Foundation and 86 other organizations called on Congress to protect Medicaid, a critical source of coverage for people in the cystic fibrosis community.
News
|
March 20, 2017
|
2 min read
For many people with cystic fibrosis, dealing with insurance is as much a part of living with the disease as are nebulizers and vests. Learning more about insurance can help make sure you can get the care you need.